Klusa VZ, Isajevs S, Svirina D, Pupure J, Beitnere U, Rumaks J, Svirskis S, Jansone B, Dzirkale Z, Muceniece R, Kalvinsh I, Vinters HV (2010) Neuroprotective properties of mildronate, a small molecule, in a rat model of Parkinson's disease
Nevertheless, their excessive activation may also result in immunopathological damage, indicating that targeting the PRR pathway necessitates careful consideration of both spatiotemporal specificity and the homeostasis of the host microenvironment
For example, disagreements over genetic confounding and the proper interpretation of individual studies should not automatically make an experts entire methodology inadmissible
*GDU to jednostka miary okrelajca moc lub aktywno enzymatyczn bromelainy
Compound heterozygotes can manifest later in life